Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 1858-1869

  Joseph, Sarah B ^a   Arrildt, Kathryn T ^a   Swanstrom, Adrienne E ^b   Schnell, Gretja ^a,d   Lee, Benhur ^c,e   Hoxie, James A ^b   Swanstrom, Ronald ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ABBVIE INC   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS, CD4; BIOLOGICAL EVOLUTION; CD4-POSITIVE T-LYMPHOCYTES; CLONING, MOLECULAR; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FLOW CYTOMETRY; HEK293 CELLS; HIV-1; HUMANS; LUCIFERASES; MACROPHAGES; PHENOTYPE; VIRUS INTERNALIZATION;

EID: 84893516528     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02477-13     Document Type: Article

References (68)

1. Arrildt K, Joseph SB, Swanstrom R. 2012. The HIV-1 ENV protein: a coat of many colors. Curr. HIV/AIDS Rep. 9:52-63. http://dx.doi.org/10.1007/s11904-011-0107-3.
2. Zamarchi R, Allavena P, Borsetti A, Stievano L, Tosello V, Marcato N, Esposito G, Roni V, Paganin C, Bianchi G, Titti F, Verani P, Gerosa G, Amadori A. 2002. Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes. Clin. Exp. Immunol. 127:321-330. http://dx.doi.org/10.1046/j.1365-2249.2002.01775.x.
3. Pace MJ, Agosto L, O'Doherty U. 2011. R5 HIV env and vesicular stomatitis virus G protein cooperate to mediate fusion to naive CD4(+) T cells. J. Virol. 85:644-648. http://dx.doi.org/10.1128/JVI.01851-10.
4. van't Wout AB, Kootstra NA, Mulderkampinga GA, Albrechtvanlent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94:2060-2067. http://dx.doi.org/10.1172/JCI117560.
5. Zhu TF, Mo HM, Wang N, Nam DS, Cao YZ, Koup RA, Ho DD. 1993. Genotypicandphenotypiccharacterization ofHIV-1patientswithprimaryinfection. Science 261:1179-1181. http://dx.doi.org/10.1126/science.8356453.
6. Braathen LR, Ramirez G, Kunze ROF, Gelderblom H. 1987. Langerhans cells as primary target cells for HIV infection. Lancet ii:1094.
7. Palacio J, Souberbielle BE, Shattock RJ, Robinson G, Manyonda I, Griffin GE. 1994. In vitro HIV1 infection of human cervical tissue. Res. Virol. 145:155-161. http://dx.doi.org/10.1016/S0923-2516(07)80017-3.
8. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, Perelson AS, Eron JJ, Cohen MS, Hicks CB, Haynes BF, Markowitz M, Keele BF, Hahn BH, Shaw GM. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 6:e1000890. http://dx.doi.org/10.1371/journal.ppat.1000890.
9. Ochsenbauer C, Edmonds TG, Ding HT, Keele BF, Decker J, Salazar MG, Salazar-Gonzalez JF, Shattock R, Haynes BF, Shaw GM, Hahn BH, Kappes JC. 2012. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 86:2715-2728. http://dx.doi.org/10.1128/JVI.06157-11.
10. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang SY, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206:1273-1289. http://dx.doi.org/10.1084/jem.20090378.
11. Isaacman-Beck J, Hermann EA, Yi YJ, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, Collman RG. 2009. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 83:8208-8220. http://dx.doi.org/10.1128/JVI.00296-09.
12. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219. http://dx.doi.org/10.1126/science.3014648.
13. Dunfee R, Thomas ER, Gorry PR, Wang JB, Ancuta P, Gabuzda D. 2006. Mechanisms of HIV-1 neurotropism. Curr. HIV Res. 4:267-278. http://dx.doi.org/10.2174/157016206777709500.
14. Duenas-Decamp MJ, Peters PJ, Burton D, Clapham PR. 2009. Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes. J. Virol. 83:2575-2583. http://dx.doi.org/10.1128/JVI.02133-08.
15. Gorry PR, Taylor J, Holm GH, Mehle A, Morgan T, Cayabyab M, Farzan M, Wang H, Bell JE, Kunstman K, Moore JP, Wolinsky SM, Gabuzda D. 2002. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J. Virol. 76:6277-6292. http://dx.doi.org/10.1128/JVI.76.12.6277-6292.2002.
16. Martin-Garcia J, Cao W, Varela-Robena A, Plassmeyer ML, Gonzalez-Scarano F. 2006. HIV-1 tropism for the central nervous system: brainderived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor. Virology 346:169-179. http://dx.doi.org/10.1016/j.virol.2005.10.031.
17. Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, Bell J, Simmonds P, Clapham PR. 2004. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J. Virol. 78:6915-6926. http://dx.doi.org/10.1128/JVI.78.13.6915-6926.2004.
18. Peters PJ, Sullivan WM, Duenas-Decamp MJ, Bhattacharya J, Ankghuambom C, Brown R, Luzuriaga K, Bell J, Simmonds P, Ball J, Clapham PR. 2006. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. J. Virol. 80:6324-6332. http://dx.doi.org/10.1128/JVI.02328-05.
19. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky SM, Gabuzda D. 2001. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J. Virol. 75:10073-10089. http://dx.doi.org/10.1128/JVI.75.21.10073-10089.2001.
20. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY. 1987. Dual infection of the central-nervous-system by AIDS viruses with distinct cellular tropisms. Science 236:819-822. http://dx.doi.org/10.1126/science.3646751.
21. Li S, Juarez J, Alali M, Dwyer D, Collman R, Cunningham A, Naif HM. 1999. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 73:9741-9755.
22. Gray L, Sterjovski J, Churchill M, Ellery P, Nasr N, Lewin SR, Crowe SM, Wesselingh SL, Cunningham AL, Gorry PR. 2005. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 337:384-398. http://dx.doi.org/10.1016/j.virol.2005.04.034.
23. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. 2011. HIV-1 replication in the central nervous system occurs intwodistinct cell types.PLoSPathog. 7:e1002286. http://dx.doi.org/10.1371/journal.ppat.1002286.
24. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. 2009. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells insomesubjects with HIV-1-associated dementia.PLoSPathog. 5:e1000395. http://dx.doi.org/10.1371/journal.ppat.1000395.
25. Churchill M, Nath A. 2013. Where does HIV hide? A focus on the central nervous system. Curr. Opin. HIV AIDS 8:165-169. http://dx.doi.org/10.1097/COH.0b013e32835fc601.
26. Johnston SH, Lobritz MA, Nguyen S, Lassen K, Delair S, Posta F, Bryson YJ, Arts EJ, Chou T, Lee B. 2009. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J. Virol. 83:11016-11026. http://dx.doi.org/10.1128/JVI.01242-09.
27. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW. 1999. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS 13:1051-1061. http://dx.doi.org/10.1097/00002030-199906180-00008.
28. Ping LH, Joseph SB, Anderson JA, Abrahams MR, Salazar-Gonzalez JF, Kincer LP, Treurnicht FK, Arney L, Ojeda S, Zhang M, Keys J, Potter EL, Chu H, Moore P, Salazar MG, Iyer S, Jabara C, Kirchherr J, Mapanje C, Ngandu N, Seoighe C, Hoffman I, Gao F, Tang Y, Labranche C, Lee B, Saville A, Vermeulen M, Fiscus S, Morris L, Karim SA, Haynes BF, Shaw GM, Korber BT, Hahn BH, Cohen MS, Montefiori D, Williamson C, Swanstrom R. 2013. Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. J. Virol. 87:7218-7233. http://dx.doi.org/10.1128/JVI.03577-12.
29. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen MS, Karim SA, Haynes BF, Shaw GM, Hahn BH, Korber BT, Swanstrom R, Williamson C. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567. http://dx.doi.org/10.1128/JVI.02132-08.
30. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun CX, Grayson T, Wang SY, Li H, Wei XP, Jiang CL, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 105:7552-7557. http://dx.doi.org/10.1073/pnas.0802203105.
31. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, Manigart O, Mulenga J, Anderson JA, Swanstrom R, Haynes BF, Athreya GS, Korber BTM, Sharp PM, Shaw GM, Hahn BH. 2008. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82:3952-3970. http://dx.doi.org/10.1128/JVI.02660-07.
32. Del Prete GQ, Haggarty B, Leslie GJ, Jordan APO, Romano J, Wang N, Wang JB, Holmes MC, Montefiori DC, Hoxie JA. 2009. Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4. J. Virol. 83:9911-9922. http://dx.doi.org/10.1128/JVI.00533-09.
33. Rucker J, Doranz BJ, Edinger AL, Long D, Berson JF, Doms RW. 1997. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry. Methods Enzymol. 288:118-133.
34. Naif HM, Li S, Alali M, Sloane A, Wu LJ, Kelly M, Lynch G, Lloyd A, Cunningham AL. 1998. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72:830-836.
35. Sonza S, Maerz A, Uren S, Violo A, Hunter S, Boyle W, Crowe S. 1995. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression. AIDS Res. Hum. Retroviruses 11:769-776. http://dx.doi.org/10.1089/aid.1995.11.769.
36. Wynn TA, Chawla A, Pollard JW. 2013. Macrophage biology in development, homeostasis and disease. Nature 496:445-455. http://dx.doi.org/10.1038/nature12034.
37. Polazzi E, Monti B. 2010. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog. Neurobiol. 92:293-315. http://dx.doi.org/10.1016/j.pneurobio.2010.06.009.
38. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841-845. http://dx.doi.org/10.1126/science.1194637.
39. Schulz C, Perdiguero EG, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu BS, Jacobsen SEW, Pollard JW, Frampton J, Liu KJ, Geissmann F. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336:86-90. http://dx.doi.org/10.1126/science.1219179.
40. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456-1458. http://dx.doi.org/10.1126/science.1202529.
41. Sierra A, Encinas JM, Deudero JJP, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, Tsirka SE, Maletic-Savatic M. 2010. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7:483-495. http://dx.doi.org/10.1016/j.stem.2010.08.014.
42. Unger ER, Sung JH, Manivel JC, Chenggis ML, Blazar BR, Krivit W. 1993. Male donor-derived cells in the brains of female sex-mismatched bone-marrow transplant recipients-a Y-chromosome specific in-situ hybridization study. J. Neuropathol. Exp. Neurol. 52:460-470. http://dx.doi.org/10.1097/00005072-199309000-00004.
43. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA. 2001. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193:905-915. http://dx.doi.org/10.1084/jem.193.8.905.
44. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, Topham DJ, Pierce RH, Crispe IN. 2007. Kupffer cell heterogeneity: functional properties of bone marrow-derived and sessile hepatic macrophages. Blood 110:4077-4085. http://dx.doi.org/10.1182/blood-2007-02-073841.
45. Murray PJ, Wynn TA. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11:723-737. http://dx.doi.org/10.1038/nri3073.
46. London A, Cohen M, Schwartz M. 2013. Microglia and monocytederived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front. Cell Neurosci. 7:34. http://dx.doi.org/10.3389/fncel.2013.00034.
47. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969. http://dx.doi.org/10.1038/nri2448.
48. Crain JM, Nikodemova M, Watters JJ. 2013. Microglia express distinct M1andM2phenotypic markers in the postnatal and adult central nervous system in male and female mice. J. Neurosci. Res. 91:1143-1151. http://dx.doi.org/10.1002/jnr.23242.
49. Gibbings D, Befus AD. 2009. CD4 and CD8: an inside-out coreceptor model for innate immune cells. J. Leukoc. Biol. 86:251-259. http://dx.doi.org/10.1189/jlb.0109040.
50. Crocker PR, Jefferies WA, Clark SJ, Chung LP, Gordon S. 1987. Species heterogeneity in macrophage expression of the CD4 antigen. J. Exp. Med. 166:613-618. http://dx.doi.org/10.1084/jem.166.2.613.
51. Duncan CJA, Sattentau QJ. 2011. Viral determinants of HIV-1 macrophage tropism. Viruses 3:2255-2279. http://dx.doi.org/10.3390/v3112255.
52. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U.S.A. 96:5215-5220. http://dx.doi.org/10.1073/pnas.96.9.5215.
53. Thomas ER, Dunfee RL, Stanton J, Bogdan D, Taylor J, Kunstman K, Bell JE, Wolinsky SM, Gabuzda D. 2007. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 360:105-119. http://dx.doi.org/10.1016/j.virol.2006.09.036.
54. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, Meltzer MS. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428-1441. http://dx.doi.org/10.1084/jem.167.4.1428.
55. Li YX, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue-identification of replication-competent and replication-defective viral genomes. J. Virol. 65:3973-3985.
56. Sturdevant CB, Dow A, Jabara CB, Joseph SB, Schnell G, Takamune N, Mallewa M, Heyderman RS, Van Rie A, Swanstrom R. 2012. Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children. PLoS Pathog. 8:e1003094. http://dx.doi.org/10.1371/journal.ppat.1003094.
57. Salimi H, Roche M, Webb N, Gray LR, Chikere K, Sterjovski J, Ellett A, Wesselingh SL, Ramsland PA, Lee B, Churchill MJ, Gorry PR. 2013. Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5. J. Leukoc. Biol. 93:113-126. http://dx.doi.org/10.1189/jlb.0612308.
58. Ortiz AM, Klatt NR, Li B, Yi Y, Tabb B, Hao XP, Sternberg L, Lawson B, Carnathan PM, Cramer EM, Engram JC, Little DM, Ryzhova E, Gonzalez-Scarano F, Paiardini M, Ansari AA, Ratcliffe S, Else JG, Brenchley JM, Collman RG, Estes JD, Derdeyn CA, Silvestri G. 2011. Depletion of CD4(+) T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J. Clin. Invest. 121:4433-4445. http://dx.doi.org/10.1172/JCI46023.
59. Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, Hirsch V, Martin MA. 2001. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4(+) T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. U.S.A. 98:658-663. http://dx.doi.org/10.1073/pnas.98.2.658.
60. Peters PJ, Duenas-Decamp MJ, Sullivan WM, Brown R, Ankghuambom C, Luzuriaga K, Robinson J, Burton DR, Bell J, Simmonds P, Ball J, Clapham PR. 2008. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope:CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology 5:5. http://dx.doi.org/10.1186/1742-4690-5-5.
61. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR. 2009. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 66:253-258. http://dx.doi.org/10.1002/ana.21697.
62. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE. 2000. Renal epithelium is a previously unrecognized site of HIV-1 infection. J. Am. Soc. Nephrol. 11:2079-2087.
63. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klotman PE. 2002. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat. Med. 8:522-526. http://dx.doi.org/10.1038/nm0502-522.
64. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, Wesselingh SL, Purcell DFJ. 2003. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr. HIV Res. 1:463-473. http://dx.doi.org/10.2174/1570162033485122.
65. Thompson KA, Churchill MJ, Gorry PR, Sterjovski J, Oelrichs RB, Wesselingh SL, McLean CA. 2004. Astrocyte specific viral strains in HIV dementia. Ann. Neurol. 56:873-877. http://dx.doi.org/10.1002/ana.20304.
66. Zhu TF, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L. 2002. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76:707-716. http://dx.doi.org/10.1128/JVI.76.2.707-716.2002.
67. Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H. 2008. Maraviroc for previously treated patients with R5 HIV-1 infection. N. Engl. J. Med. 359:1429-1441. http://dx.doi.org/10.1056/NEJMoa0803152.
68. Stephenson J. 2007. Researchers buoyed by novel HIV drugs-will expand drug arsenal against resistant virus. JAMA 297:1535-1536. http://dx.doi.org/10.1001/jama.297.14.1535.